Unlocking the Medicinal Power of COVID-19 to Fight Glioblastoma
The COVID-19 pandemic has caused a great deal of disruption, but researchers are now looking to this virus to provide potential treatments for other diseases. A recent study has explored the potential use of SARS-CoV-2, the virus that causes COVID-19, to treat glioblastoma, a deadly type of brain cancer. The study, published in the journal Cell Reports Medicine, is the first to demonstrate the therapeutic potential of using SARS-CoV-2 to fight glioblastoma.
The researchers used a laboratory model of the virus to study its effects on glioblastoma cells. They found that the SARS-CoV-2 virus was able to infiltrate and kill glioblastoma cells, while leaving healthy cells unharmed. The team then tested the virus in a mouse model of glioblastoma and found that it was able to reduce tumor growth.
These findings suggest that SARS-CoV-2 could be a powerful tool in the fight against glioblastoma. While further research is needed to confirm the efficacy of this approach, the results of the study provide hope that COVID-19 could be used to help treat this devastating
source: Phys.org